JP Patent

JP7138666B2 — γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法

Assigned to Ohara Pharmaceutical Co Ltd · Expires 2022-09-16 · 4y expired

What this patent protects

Patent listed against Lyrica.

Drugs covered by this patent

Lyrica (Pregabalin) · Pfizer Inc.

Patent Metadata

Patent number: JP7138666B2
Jurisdiction: JP
Classification: —
Expires: 2022-09-16
Drug substance claim: No
Drug product claim: No
Assignee: Ohara Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.